Acute retroperitoneal hematoma following severe Covid-19 and the use of anticoagulants

INTRODUCTION: and Importance: Severe COVID19 patients under anticoagulant therapy are at the risk of developing hematoma. CASE PRESENTATION: We present case of 11 COVID19 who were presented with localized skin ecchymosis lesions in different areas of the body and retroperitoneal hematoma in the post...

Descripción completa

Detalles Bibliográficos
Autores principales: Marzban-Rad, Saeid, Bahmani, Sahar, Kazemi, Amenehsadat, Taheri, Hamid Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173825/
https://www.ncbi.nlm.nih.gov/pubmed/35693103
http://dx.doi.org/10.1016/j.amsu.2022.103909
_version_ 1784722104289067008
author Marzban-Rad, Saeid
Bahmani, Sahar
Kazemi, Amenehsadat
Taheri, Hamid Reza
author_facet Marzban-Rad, Saeid
Bahmani, Sahar
Kazemi, Amenehsadat
Taheri, Hamid Reza
author_sort Marzban-Rad, Saeid
collection PubMed
description INTRODUCTION: and Importance: Severe COVID19 patients under anticoagulant therapy are at the risk of developing hematoma. CASE PRESENTATION: We present case of 11 COVID19 who were presented with localized skin ecchymosis lesions in different areas of the body and retroperitoneal hematoma in the posterior wall of the abdomen and chest. CLINICAL DISCUSSION: Cases of hematoma with severe COVID19 patients under anticoagulant therapy are reported in several case studies, particularly in geriatric population with the previous history of blood and/or cardiac disorders. CONCLUSION: These patients should be carefully monitored for hematomas by skilled nurse and practitioner and timely treated and monitored. -
format Online
Article
Text
id pubmed-9173825
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91738252022-06-08 Acute retroperitoneal hematoma following severe Covid-19 and the use of anticoagulants Marzban-Rad, Saeid Bahmani, Sahar Kazemi, Amenehsadat Taheri, Hamid Reza Ann Med Surg (Lond) Case Series INTRODUCTION: and Importance: Severe COVID19 patients under anticoagulant therapy are at the risk of developing hematoma. CASE PRESENTATION: We present case of 11 COVID19 who were presented with localized skin ecchymosis lesions in different areas of the body and retroperitoneal hematoma in the posterior wall of the abdomen and chest. CLINICAL DISCUSSION: Cases of hematoma with severe COVID19 patients under anticoagulant therapy are reported in several case studies, particularly in geriatric population with the previous history of blood and/or cardiac disorders. CONCLUSION: These patients should be carefully monitored for hematomas by skilled nurse and practitioner and timely treated and monitored. - Elsevier 2022-06-07 /pmc/articles/PMC9173825/ /pubmed/35693103 http://dx.doi.org/10.1016/j.amsu.2022.103909 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Series
Marzban-Rad, Saeid
Bahmani, Sahar
Kazemi, Amenehsadat
Taheri, Hamid Reza
Acute retroperitoneal hematoma following severe Covid-19 and the use of anticoagulants
title Acute retroperitoneal hematoma following severe Covid-19 and the use of anticoagulants
title_full Acute retroperitoneal hematoma following severe Covid-19 and the use of anticoagulants
title_fullStr Acute retroperitoneal hematoma following severe Covid-19 and the use of anticoagulants
title_full_unstemmed Acute retroperitoneal hematoma following severe Covid-19 and the use of anticoagulants
title_short Acute retroperitoneal hematoma following severe Covid-19 and the use of anticoagulants
title_sort acute retroperitoneal hematoma following severe covid-19 and the use of anticoagulants
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173825/
https://www.ncbi.nlm.nih.gov/pubmed/35693103
http://dx.doi.org/10.1016/j.amsu.2022.103909
work_keys_str_mv AT marzbanradsaeid acuteretroperitonealhematomafollowingseverecovid19andtheuseofanticoagulants
AT bahmanisahar acuteretroperitonealhematomafollowingseverecovid19andtheuseofanticoagulants
AT kazemiamenehsadat acuteretroperitonealhematomafollowingseverecovid19andtheuseofanticoagulants
AT taherihamidreza acuteretroperitonealhematomafollowingseverecovid19andtheuseofanticoagulants

Ejemplares similares